Search
Now showing items 1-1 of 1
Dissection of drug resistance mechanisms in FGFR2 mutant endometrial cancer.
(Queen Mary University of London, 2015-01)
Mutations in FGFR2 are common in a subset of endometrial carcinomas. Given the emergence of small molecule inhibitors specific to this receptor tyrosine kinase, FGFR2 is an attractive therapeutic target. However, compensatory ...